JR

Jyoti Ranjan Pattanayak

Active Director Director DIN 10351511
DIN 10351511 First appointment Oct 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Jyoti Ranjan Pattanayak

Data last updated:

Jyoti Ranjan Pattanayak is a Director at Zeomedic Pharmaceutical Private Limited (since 2023). The company operates in Pharma.

DIN 10351511
Primary Designation Director
Industry Pharma
First Appointment 12 Oct 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Oct 20232023Active

Board colleagues of Jyoti Ranjan Pattanayak

NameDINCompanyDesignation
Sumita Bala Nayak10351512Zeomedic Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Zeomedic Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Jyoti Ranjan Pattanayak

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jyoti Ranjan Pattanayak

Jyoti Ranjan Pattanayak currently holds 1 directorship: Zeomedic Pharmaceutical Private Limited (Director, since 12 Oct 2023).

Jyoti Ranjan Pattanayak was first appointed on 12 Oct 2023 as Director at Zeomedic Pharmaceutical Private Limited.

The current boards of Jyoti Ranjan Pattanayak's companies include Sumita Bala Nayak (Zeomedic Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available